LILM - RIOT MARA and HIVE among pre market gainers

CTI BioPharma (NASDAQ:CTIC) +55% announces FDA accelerated approval of VONJ (pacritinib) for the treatment of adult patients with myelofibrosis and thrombocytopenia. American Rebel (NASDAQ:AREB) +24%. 3D Systems DDD +14% on Q4 results. Lilium N.V. (NASDAQ:LILM) +8%. Editas Medicine EDIT +11% rides on patent win for Broad Institute in CRISPR gene editing. Target TGT +11% on Q4 results. 51job JOBS +10% after report buyout group nearing $61/share takeout. Atea Pharmaceuticals AVIR +10% on Q4 results. LivePerson LPSN +11% after activist Starboard takes stake. Marathon Digital Holdings (NASDAQ:MARA) +9%. Redbox Entertainment (NASDAQ:RDBX) +9%. Riot Blockchain (NASDAQ:RIOT) +7%. Legend Biotech LEGN +8% J&J, Legend Biotech's Carvykti for multiple myeloma gets US FDA approval. Hut 8 Mining (NASDAQ:HUT) +7%. Cabaletta Bio (NASDAQ:CABA) +7% U.S. Food and Drug Administration grants Cabaletta bio fast track designation for MuSK-CAART. Bitfarms BITF +7% mines 67% more new BTC in February from prior year. Equinor EQNR +7% BP planning to sell Rosneft stake to ... Rosneft. Sphere 3D (NASDAQ:ANY) +7%. Chico's FAS CHS +6% on Q4 results. Bakkt

For further details see:

RIOT, MARA and HIVE among pre market gainers